AI for Drug Discovery Needs Trustworthy Biological Data

Researchers are developing new frameworks to improve the quality of biological data used in AI-driven drug discovery and cancer diagnostics. By establishing more reliable data foundations, these initiatives aim to address concerns regarding the accuracy and consistency of medical AI outcomes. These efforts are intended to move machine learning models beyond experimental use by ensuring the underlying biological information is precise enough for clinical decision-making.